Codetta Bio Announces Commercial Availability of Concerto™ System and New Customizable Cytokine and Neuroscience Panels at AGBT 2026

Codetta Bio™, a leader in multi-omic solutions that combine ultrasensitive protein quantification with simultaneous RNA and DNA analysis, today announced major product and commercialization milestones at the AGBT General Meeting. The company has transitioned its Concerto™ system to commercial production and has begun installing systems at customer sites. Codetta Bio also unveiled its near-term product roadmap, including the upcoming launch of new customizable panels for multi-omic studies of immunology and neuroscience.

3ME Technology and South 8 Technologies Sign Letter of Intent to Advance Extreme Cold‑Weather Battery Solutions for Defense

South 8 Technologies, a San Diego-based innovator redefining lithium-ion battery performance with its patented LiGas® cell technology, has signed a Letter of Intent (LOI) with 3ME Technology, an Australian‑owned specialist in ultra‑safe lithium‑ion battery systems for defense, mining and maritime operations, to collaborate on the development of next‑generation lithium‑ion battery solutions designed for extreme cold‑weather and Arctic defense operations.

AM Batteries Names Former Maxwell CEO Dr. Franz Fink Chief Commercial Officer to Lead Dry Battery Electrode (DBE) 2.0 Commercialization

AM Batteries (AMB), a pioneer in low-cost, dry-electrode manufacturing technology, today announced that Dr. Franz Fink has joined the company as Chief Commercial Officer.

In this strategic role, Dr. Fink will lead AMB’s commercial efforts to accelerate the industry’s adoption of AMB’s proprietary Dry Battery Electrode (DBE) technology through the sale of high-performance electrodes and specialized manufacturing equipment.

ExOne Global Holdings Announces Board of Directors

ExOne Global Holdings (“ExOne Global” or the “Company”) today announced its Board of Directors, bringing together industrial technology operators, investors, and additive manufacturing leaders with global experience across commercialization, capital formation, and operational execution. The Board will support ExOne Global’s strategic priorities, including disciplined scaling, international market development, and partnership-led growth.

Niron Magnetics Opens Washington, D.C. Office to Advance Permanent Magnet Supply Chain Independence

Niron Magnetics, the company manufacturing high-performance Iron Nitride permanent magnets made without rare earths, today announced the opening of a Washington, D.C. office to work more closely with the federal government on reducing America’s dependence on foreign permanent magnets. With a presence in the nation’s capital, Niron Magnetics will leverage its breakthrough Iron Nitride permanent magnet technology to become a central partner in U.S. efforts to secure domestic magnet supply chains for critical applications, including motor vehicles, defense systems, and consumer electronics.

Axion BioSystems Acquires High-Throughput, High-Density CMOS MEA Technology from CytoTronics

Axion BioSystems, a leading life sciences tools company focused on cutting-edge live-cell bioelectronic assay and imaging systems, announces the acquisition of the intellectual property and assets of CytoTronics, Inc. The purchase brings novel high-density (HD) electrode array technology developed at Harvard University to Axion’s growing product suite and strengthens Axion’s ability to provide researchers with the most advanced tools for disease research and drug discovery.

NTx Bio Appoints Dr. Joan Haab as Chief Executive Officer

NTx Bio, a leader in next-generation biomanufacturing technologies, today announced that Joan Haab, Ph.D., has been appointed as CEO by the Company Board of Directors. Dr. Haab previously served as Chief Operating Officer, and succeeds Jamie Coffin, Ph.D., who stepped down as CEO to focus on personal matters.